ROFERON-A

This brand name is authorized in Austria, Brazil, Estonia, Lithuania, Malta, Poland, Singapore, Spain.

Active ingredients

The drug ROFERON-A contains one active pharmaceutical ingredient (API):

1
UNII 47RRR83SK7 - INTERFERON ALFA-2A
 
Read more about Interferon, alfa-2a

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L03AB04 Interferon alfa-2a L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons
Discover more medicines within L03AB04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
BR Câmara de Regulação do Mercado de Medicamentos 529205304151319, 529205306152312, 529205308155319
EE Ravimiamet 1163797, 1163809, 1163810, 1163821, 1163832, 1163854, 1163865, 1163876, 1163887, 1163898, 1820270, 1826423, 1826524
ES Centro de información online de medicamentos de la AEMPS 62994, 62999
LT Valstybinė vaistų kontrolės tarnyba 1081950, 1088258
MT Medicines Authority AA565/48601
PL Rejestru Produktów Leczniczych 100091790, 100091815, 100091821
SG Health Sciences Authority 10296P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈